相关实验视频
Updated: Jun 6, 2025

16:11
Implantation of the Syncardia Total Artificial Heart
Published on: July 18, 2014
35.2K
手术前右心室功能对患有心室辅助器件的患者急性功能衰竭发展的影响
Deniz S Beyazpınar1, Mehmet Emir Erol2
1Department of Cardiovascular Surgery, Baskent University Faculty of Medicine, Ankara, TUR.
Cureus
|November 26, 2024
概括
手术前的右心室功能会影响左心室辅助器件 (LVAD) 植入后的脏健康. 下三环状平面缩外流 (TAPSE) 预测急性损伤 (AKI),强调其在患者护理中的重要性.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 心血管外科心血管外科
背景情况:
- 急性损伤 (AKI) 和急性衰竭是左心室辅助器件 (LVAD) 患者的重大并发症,导致高死亡率和发病率.
- 手术前右心室功能对LVAD患者急性功能衰竭的发展的影响是一个需要进一步研究的领域.
研究的目的:
- 调查手术前右心室功能与手术后AKI发生率在接受LVAD植入的患者之间的相关性.
- 为了确定LVAD手术后功能障碍的预测参数.
主要方法:
- 在2012年4月至2021年12月期间接受LVAD植入的61名患者的回顾性分析.
- 使用胸前心声学评估手术前的右心室功能,重点关注三环状平面缩外流 (TAPSE) 和右心室分数面积变化 (FAC).
- 统计分析以确定术前右心室功能参数与术后AKI发展之间的关联.
主要成果:
- 较低的术前TAPSE值被确定为术后AKI的显著风险因素 (p = 0.02).
- 术前血清肌水平升高,年龄较大和身体表面积较大也与增加AKI风险有关.
- 在手术前的右心室分数面积变化 (FAC) 和AKI发病率之间没有发现显著的相关性.
结论:
- 在手术前的三环状平面缩外流 (TAPSE) 是一个更可靠的预测术后功能障碍的LVAD患者与右心室分数面积变化 (FAC) 相比.
- 在手术前评估右心室功能对于 LVAD 患者的风险分层和管理至关重要,以预防 AKI.
相关概念视频
Heart Failure Drugs: Diuretics
343
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
343
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
386
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
386
Factors Affecting Renal Clearance: Renal Impairment
54
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
54
Mitral Regurgitation I: Introduction
4
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
4
Renal Failure: Dose Adjustments
64
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
64
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K

